Cutaneous Pseudolymphoma Derived from Ruptured Milia

DOI QR Code

Lee, Minseok (Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine) ;
Kim, Jemin (Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine) ;
Kim, Do Young (Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine)

Bergman R. Pseudolymphoma and cutaneous lymphoma: facts and controversies. Clin Dermatol 2010;28:568-574. https://doi.org/10.1016/j.clindermatol.2010.04.005
Cristaudo A, Forte G, Bocca B, Petrucci F, Muscardin L, Trento E, et al. Permanent tattoos: evidence of pseudolymphoma in three patients and metal composition of the dyes. Eur J Dermatol 2012;22:776-780.
Imafuku S, Ito K, Nakayama J. Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis. Br J Dermatol 2012;166:675-678. https://doi.org/10.1111/j.1365-2133.2011.10607.x
Nihal M, Mikkola D, Horvath N, Gilliam AC, Stevens SR, Spiro TP, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol 2003;34:617-622. https://doi.org/10.1016/S0046-8177(03)00075-3
Burg G, Dummer R, Haeffner A, Kempf W, Kadin M. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol 2001;137:949-952.